OAM
OPTR

Oxford Asset Management’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

Oxford Asset Management’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-838,763
Closed -$10.6M – 936
2013
Q3 		$10.6M Buy
838,763
+648,160
+340% +$8.59M 0.24% 91
2013
Q2 		$2.76M Buy
+190,603
New +$2.78M 0.07% 393

Oxford Asset Management's OPTR Position: Q4 2013 in Review

Oxford Asset Management sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 838,763 shares — an estimated $10.6M sold.

Oxford Asset Management first reported a position in OPTR in Q2 2013 and held it in 2 quarters. The position peaked at $10.6M in Q3 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • Oxford Asset Management reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • Oxford Asset Management sold 838,763 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $10.6M.
  • Oxford Asset Management first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q2 2013 and held it in 2 quarters.
  • Oxford Asset Management's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $10.6M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on Oxford Asset Management's 13F filing for Q4 2013, filed 22 Jan 2014.